Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2001Journal of the American Society of Nephrology

Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations

View Full Paper
Ask AI
Bookmark
Share

Authors

HPHemangshu PodderCornell UniversitySSStanislaw M. StepkowskiUniversity of Toledo Medical CenterKNKimberly L. NapoliSt George's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Podder et al. (2001) studied this question.

synapsesocial.com/papers/6a926197cf08077344f0cb3fhttps://doi.org/10.1681/asn.v1251059
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTS1995 · 109 citations
  2. 2Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood1990 · 88 citations
  3. 3Involvement of reactive oxygen species in kidney damage1993 · 158 citations
  4. 4IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION11998 · 292 citations